Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Coitus × lenvatinib × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Carcinoma, Hepatocellular 31 Cholangiocarcinoma 11 Carcinoma, Renal Cell 6 Stomach Neoplasms 5 Neoplasms 4 Liver Neoplasms 4 Endometrial Neoplasms 3 Biliary Tract Neoplasms 3 Uterine Cervical Neoplasms 2 Triple Negative Breast Neoplasms 2 Thyroid Neoplasms 2 Small Cell Lung Carcinoma 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Ovarian Neoplasms 2 Kidney Neoplasms 2 Cirrhosis, Familial, with Pulmonary Hypertension 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms 2 Advanced Solid Tumor 2 Vulvar Neoplasms 1 Urogenital Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Thymoma 1 Solid Tumor, Adult 1 Solid Tumor 1 Sarcoma 1 Recurrence 1 Pancreatic Neoplasms 1 Ovarian Diseases 1 Neuroendocrine Tumors 1

Interventions

oncomodulin 1 lenvatinib 1 Surveys and Questionnaires 1 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1 Focus Groups 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05789667 2024-12-06

Gisel

Regina Elena Cancer Institute

Coitus

Data powered by HemOnc (CC BY 4.0) Colophon ⚡